Business, energy, technology, markets and global industry news from Business News Today

Minghui Pharmaceutical

PharmaDeviceNews Minghui Pharmaceutical
Representative image of an ophthalmology exam setting as Minghui Pharmaceutical’s MHB018A data sharpen interest in subcutaneous IGF-1R antibody therapy for thyroid eye disease.
Pharma & Biotech

Can Minghui Pharmaceutical’s MHB018A challenge established thyroid eye disease therapies?

Find out how Minghui Pharmaceutical’s MHB018A could reshape thyroid eye disease treatment as Phase III trials test its promise.

Read More
Pharma & Biotech

Minghui and Qilu push MHB088C forward as prostate cancer ADC race tightens

Minghui and Qilu’s MHB088C data show durable disease control in mCRPC. Find out why the B7-H3 ADC still faces key clinical tests.

Read More